Search results for
2023/24 review: Maintaining trust in the safe use of human tissue
We work to ensure the safe and trusted use of human tissue in our regulated sectors by improving compliance, supporting innovation and developing a strong...
2023/24 review: Supporting our licensed establishments to overcome challenges
As well as providing regulatory oversight and guidance to our sectors, we take an active role in supporting our establishments to ensure they deliver to a...
2023/24 review: Shortfalls
When we inspect an establishment, we assess the premises, review their records, operational policies and procedures, and observe practices.
2023/24 review: Serious Incidents
We require establishments in several sectors to report serious incidents that occur in areas covered by their licence.
2023/24 review: A risk-based approach
Our approach to regulation involves being attuned to the risks, taking a targeted – yet proportionate – approach, and using the necessary regulatory too
2023/24 review: Maintaining public trust and confidence
We are an effective regulator that maintains public confidence through our licensing, inspection and authorisation processes and by being open and transpar...
HTA Board Meeting - 19 September 2024
The HTA Board meeting held in public will take place on Thursday 19 September 2024. This page includes the agenda and papers.
Unannounced inspections for the post mortem sector from September 2024
We will adopt a new approach to regulation from September 2024 when most on-site assessments of HTA post mortem licensed premises will be taking place with...
Human Tissue Authority Launches Strategy for 2024-2027
The Human Tissue Authority (HTA) has today published its strategy for 2024-2027, setting out its vision and priorities for regulating the use of human tiss...